BioHealth Capital Region Regional Life Sciences Roundup - Week of March 21, 2025
We are thrilled to launch the return of our Regional Roundup (formerly Quick Hits) which aims to deliver the most important and timely life sciences news from in and around the BioHealth Capital Region (Maryland, Washington, DC, Virginia).

Financial
TEDCO Invests in Hememics Biotechnologies, Inc. More >
Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments More >
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) More >
MacroGenics Provides Update on Corporate Progress and 2024 Financial Results More >
Avalo Reports 2024 Financial Results and Recent Business Updates More >
Precigen Reports Full Year 2024 Financial Results and Business Updates More >
CEL-SCI Announces Pricing of $2.5 Million Offering More >
Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering More >
Clinical + Commercial
IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Canadian Hamilton Health Sciences More >
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg More >
REGENXBIO Reports Positive Biomarker Data From Affinity Duchenne Trial of RGX-202 Gene Therapy More >
Welldoc Achieves 50+ Patents, Unveiling "CGM-GPT" for Advanced Glucose Prediction More >
Cellphire Therapeutics CLPH-511 Fast Track Designation Granted More >
New Multinational Study Shows MRI is Cost-Effective in the Diagnosis and Management of Steatotic Liver Disease More >
VLP Therapeutics wins investment from GHIT Fund for dengue vaccine clinical trial More >
Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease More >
CEL-SCI’s Head and Neck Cancer Registration Study Protocol Clears FDA Review—in Talks with Potential Partners Interested in Commercialization of Multikine More >
CEPI and AstraZeneca to advance discovery into novel antibody to help prevent infection during outbreaks More >
AstraZeneca goes in vivo, penning $1B deal for Belgian off-the-shelf cell therapy biotech More >
People + Workforce
Amid Federal Workforce Layoffs - Frederick, Maryland Biotech Companies Are Hiring More >
What Does Baltimore’s New “Bold Moves” Brand Mean for Biotechnology and Life Sciences? More >
Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International More >
Theradaptive Welcomes Jeffrey W. Dunn to its Board of Directors More >
Celebrated Clinical Geneticist Dr. Stephen Cederbaum to Receive 2025 David L. Rimoin Lifetime Achievement Award in Medical Genetics from the ACMG Foundation for Genetic and Genomic Medicine More >
Ecosystem Buzz
TEDCO’s Maryland Innovation Initiative Unveils RFAs for the Baltimore Innovation Initiative More >
United Therapeutics Corporation (UT) earned a spot on the first-ever Forbes America’s Best Companies list, joining the top 300 public companies in the U.S. More >
Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies More >
BioBuzz + ScienceWerx Plan Saudi Arabia Expansion More >
Montgomery College to Host Networking/Job Fair for Displaced Federal Scientists More >
Maryland Named 6th Most Innovative State in New Study More >
Maryland-Based Biotech Company Earns NASC Quality Seal for Commitment to Excellence More >
What’s the Buzz?! Cell and Gene Therapy Innovations at AstraZeneca More >
Hot Employer
MilliporeSigma (Rockville, MD)
MilliporeSigma is expanding with a new state-of-the-art, 23,000-square-meter facility will house biosafety testing, analytical development, viral clearance suites, and cell bank manufacturing services, creating over 500 new jobs over the next four years.
Available roles currently include:
-
Lab Supervisor 1 - Analytical Chemistry
-
Maintenance Equipment Tech 1
-
Senior Strategic Product Manager, Product Characterization
Other Good Reads
NIH grants powered $94B in economic activity in 2024 and supported more than 400K jobs: report More >
The Economic Power of NIH Grants: Why Sustained Investment Matters More >
"Fractional Hiring" At Your CDMO. Okay With You? More >
Did we miss something? Drop us a line!